ArticleCancer discovery2012

Resiliency of lung cancers to EGFR inhibitor treatment unveiled, offering opportunities to divide and conquer EGFR inhibitor resistance.

Collin M Blakely et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.